Clorox Company (The) (NYSE:CLX) is scheduled to post its quarterly earnings results before the market opens on Wednesday, November 1st. Analysts expect Clorox Company (The) to post earnings of $1.41 per share for the quarter. Clorox Company (The) has set its FY18 guidance at $5.52-5.72 EPS.

Clorox Company (The) (NYSE:CLX) last released its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The firm had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.65 billion. During the same period in the prior year, the business posted $1.30 earnings per share. The firm’s revenue for the quarter was up 2.9% compared to the same quarter last year. On average, analysts expect Clorox Company (The) to post $5.6 EPS for the current fiscal year and $5.93 EPS for the next fiscal year.

Clorox Company (NYSE CLX) opened at 127.21 on Wednesday. The stock has a market capitalization of $16.42 billion, a P/E ratio of 23.84 and a beta of 0.39. Clorox Company has a 52-week low of $111.24 and a 52-week high of $141.76. The company’s 50-day moving average price is $131.97 and its 200 day moving average price is $134.08.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 13th. Investors of record on Wednesday, October 25th will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Tuesday, October 24th. This represents a $3.36 dividend on an annualized basis and a yield of 2.64%. Clorox Company (The)’s payout ratio is 63.04%.

A number of analysts recently issued reports on the company. BMO Capital Markets reissued an “outperform” rating on shares of Clorox Company (The) in a research report on Tuesday, September 12th. Jefferies Group LLC reissued a “hold” rating and set a $137.00 price objective (up previously from $136.00) on shares of Clorox Company (The) in a research report on Wednesday, August 9th. Barclays PLC reissued an “equal weight” rating and set a $136.00 price objective (down previously from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. BidaskClub cut Clorox Company (The) from a “hold” rating to a “sell” rating in a research report on Wednesday, July 5th. Finally, Zacks Investment Research raised Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price objective for the company in a research report on Tuesday, July 4th. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company’s stock. Clorox Company (The) currently has a consensus rating of “Hold” and an average target price of $127.39.

TRADEMARK VIOLATION WARNING: This article was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this article on another website, it was stolen and republished in violation of United States & international copyright law. The legal version of this article can be read at https://www.americanbankingnews.com/2017/10/25/clorox-company-the-clx-to-release-earnings-on-wednesday.html.

In other news, COO Dawn C. Willoughby sold 2,158 shares of the company’s stock in a transaction that occurred on Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total value of $297,804.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP James E. Foster sold 9,861 shares of the company’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total value of $1,365,847.11. Following the completion of the sale, the executive vice president now owns 22,069 shares in the company, valued at $3,056,777.19. The disclosure for this sale can be found here. Over the last quarter, insiders sold 21,242 shares of company stock worth $2,944,449. Corporate insiders own 1.00% of the company’s stock.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Earnings History for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.